knowledge -WSS

knowledge

author：leisure time 2025-10-01 18:34:14 - browse：84545

Investment bank Goldman Sachs is jumping into the biotech world after raising $650 million to invest in privately held startups.

The bank announced Wednesday that it has closed its first-ever life sciences fund, called West Street Life Sciences I. The plan is to invest the money in genetic medicine, cell therapies, immunotherapies, synthetic biology and artificial intelligence startups, as well as diagnostics and life science tools companies.

First-time funds have been difficult to raise during the biotech downturn. Last year, around $11.6 billion was raised by 183 new VC funds, which was the lowest fundraising total for first-timers since 2013, according to Pitchbook. Around $25.6 billion had been raised by 556 first-time funds in 2022.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： Readout Newsletter: AstraZeneca's CEO, Roivant's $5 billion deal

explore

WSS

Driven by the pandemic, applicants flood public health schools

Is there really a nursing shortage in the U.S.?

Awakening the world to the whoosh: A patient's crusade

Driven by the pandemic, applicants flood public health schools

Wife of Gilgo Beach murder suspect files for divorce, court filing shows

STAT Readout Newsletter: Biotech news today

leisure time

knowledge

focus

Medical records are filled with copy

Winning ticket for $1 billion Powerball jackpot sold in California

Supreme Court strikes down use of affirmative action

Jury awards Florida girl burned by McDonald's Chicken McNugget $800,000 in damages

Medicare details structure of new drug price negotiation program

Public funding for King Charles III and royals has been recalculated due to windfarm deal profits

Anesthesiologist group: stop taking Ozempic before surgery

'Stay indoors': Escaped wild animal on the loose in Berlin prompts urgent citywide search

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Driven by the pandemic, applicants flood public health schools

focus

STAT Summit: The economic case for universal basic health care

Cassava Sciences’ Alzheimer’s clinical trials should be halted

STAT Summit: The economic case for universal basic health care

Is there really a nursing shortage in the U.S.?

Health tech investors get more selective as pandemic boom fades

STAT Summit: Doctor v. ChatGPT showed AI's promise, blind spots

leisure time

explore

hotspot

hotspot